PFM Health Sciences’s ArcelorMittal MT Stock Holding History

PFM Health Sciences’s Portfolio MT Stock Details MT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-183,797	Closed	-$4.6M	–	103
2017 Q1	$4.6M	Buy	+183,797	New	+$4.65M	0.12%	93

Other funds holding MT

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NWI Management New York $2.16B AUM 62.95% 1-Year Est. Return

TPCM

Tide Point Capital Management Old Greenwich, Connecticut $851M AUM 25.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

PFM Health Sciences's MT Position: Q2 2017 in Review

PFM Health Sciences sold out of ArcelorMittal (MT) in Q2 2017, closing a stake of 183,797 shares — an estimated $4.6M sold.

PFM Health Sciences first reported a position in MT in Q1 2017 and held it in 1 quarter. The position peaked at $4.6M in Q1 2017. 168 funds tracked by Wall St. Rank hold MT as of Q2 2017.

PFM Health Sciences reported no remaining ArcelorMittal position as of Q2 2017 after selling out during the quarter.
PFM Health Sciences sold 183,797 ArcelorMittal shares in Q2 2017, an estimated $4.6M.
PFM Health Sciences first reported a position in ArcelorMittal in Q1 2017 and held it in 1 quarter.
PFM Health Sciences's ArcelorMittal position peaked at $4.6M in Q1 2017.
168 funds tracked by Wall St. Rank held ArcelorMittal as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.